The encapsulation and release of model hydrophobic drug (Curcumin) and of model hydrophilic drug (Gentamicin) were investigated in this work.
The release of model drug from the HNT-composited hydrogel matches well with its thermo-responsive volume phase transition, and shows characteristics of well controlled release.
In vitro release of model drug VB12 was studied in the presence of Cellulase E0240 in pH 7.4 phosphate buffer at 37 °C.
In vitro release of model drug 5-aminosalicylic acid (5-ASA) was studied in the presence of Cellulase E0240 in pH 7.4 phosphate buffer at 37 °C.
The gray small rectangles indicate the asperities A1, A2, and A3 Fig. 3 Distribution of total moment release of Model 0. Each colored square represents a subfault, and each subfault is further divided into 25 point sources.
Effect of temperature/pH dependent bi-phasic (burst initial followed by sustain) release of model chemotherapeutic molecule Doxorubicin on MCF7 (breast adenocarcinoma cells from human) is investigated comprehensively including MTS assay, calcein AM/ethidium bromide assay and actin filament arrangements.
This study investigates the release of model proteins with net-positive (histone) and net-negative charge (bovine serum albumin, BSA) from various scaffolding surfaces and from encapsulated microspheres in the presence of ions, proteins, and cells.
In addition, we show with the same technique that magnetocubosomes are responsive to a low frequency alternating magnetic field (LF-AMF), which acts as an external trigger to boost the release of model drugs confined in the cubic phase.
The release of model antibiotic drug tetracycline HCl from the hydrogels has been observed more in pH 2.2 buffer hence these hydrogels are suitable for peptic ulcer caused by Helicobacter pylori.
Release of model Hirano bodies may explain why 8 month old R26CT-CRE mice exhibit reactive astrocytes.
